Modified-release hydrocortisone to provide circadian cortisol profiles.
about
Brain-skin connection: stress, inflammation and skin agingCongenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guidelineIs physiological glucocorticoid replacement important in children?Sex differences in the circadian profiles of melatonin and cortisol in plasma and urine matrices under constant routine conditionsUsefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal InsufficiencyComorbid Latent Adrenal Insufficiency with Autoimmune Thyroid DiseaseSlow wave sleep and accelerated forgetting.Interactions of the human cardiopulmonary, hormonal and body fluid systems in parabolic flight.A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasiaA pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiencyManagement of the adult with congenital adrenal hyperplasia.Circadian rhythms: from basic mechanisms to the intensive care unit.Influence of electric, magnetic, and electromagnetic fields on the circadian system: current stage of knowledgeOptimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients.A transgenic zebrafish model for monitoring glucocorticoid receptor activityCurrent practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey.Treatment and health outcomes in adults with congenital adrenal hyperplasia.Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients.Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.Absence of circadian rhythms of preterm premature rupture of membranes and preterm placental abruption.Impact of chronic hypercortisolemia on affective processing.Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case reportThe hypersensitive glucocorticoid response specifically regulates period 1 and expression of circadian genesReplication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy.Adult attachment style and cortisol responses in women in late pregnancy.Anti-Stress, Behavioural and Magnetoencephalography Effects of an L-Theanine-Based Nutrient Drink: A Randomised, Double-Blind, Placebo-Controlled, Crossover TrialInhibition of MDMA-induced increase in cortisol does not prevent acute impairment of verbal memoryCardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Novel treatment strategies in congenital adrenal hyperplasia.Subjective aggression during alcohol and cannabis intoxication before and after aggression exposure.Reduction of Cortisol Levels and Participants' Responses Following Art Making.Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe.Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic studyAcute Effects of 24-h Sleep Deprivation on Salivary Cortisol and Testosterone Concentrations and Testosterone to Cortisol Ratio Following Supplementation with Caffeine or Placebo.Adrenal cortical insufficiency--a life threatening illness with multiple etiologies.An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure.Therapy of adrenal insufficiency: an update.Cardio-metabolic consequences of glucocorticoid replacement: relevance of ultradian signalling.
P2860
Q24563348-BF71C5A8-00B5-4CB4-A501-EE22FAD43474Q24614223-7C7D70B2-B4C3-410F-8042-F11CDD461D43Q28079724-087AD962-4884-44E1-8E5B-A6AA64D17EA4Q28391241-C9D2DE4B-498C-4D8B-B6C5-0DFCD419CE17Q28547592-78CCDB80-68F7-4E92-BAF4-ED37CAA49B14Q28607675-9D122C74-6D2F-41AC-9FCE-FB1A458BDDBFQ30370893-32B67189-3358-481C-892E-4286FAE73BC1Q30577964-601CE29F-8CAC-4CCA-87E2-C225CCBD1B18Q33570221-CB94EC8C-4713-46F1-BF26-AB31F3E42592Q33659999-CF332D6D-20B1-43BD-960C-E24BE349C058Q33835797-A354E80C-B16D-4B86-ADD7-6657C716F153Q33931519-475DCD97-9478-4822-8426-271E1A6D0B1DQ33960872-3689DFEF-A07F-4DE1-8747-CEE223221D57Q34021701-4251B566-86A3-4BCE-9D4E-43FD534337A9Q34033539-C572DE1B-7C99-424B-9778-71A311DB50FFQ34180545-480413A3-304D-43C0-8A6C-6A07892D1407Q34257797-7D430645-CCDD-424F-A850-F65D1221EEBBQ34303186-DC052C6A-702B-4BCA-9451-6316A76AA4D2Q34392232-EF18F5D2-2B76-49F4-AF96-FA080FEA661DQ34734248-E1264CB2-AC82-4424-AE0E-3BCF96E481B3Q34794021-79899898-72D6-4099-9FC8-F81187959345Q35163932-52089E2A-3EBF-4A67-9176-59E63024A783Q35380838-6AFFD523-41E7-40BB-9DE5-6E67D539FC63Q35820948-DC1B5554-DEA3-4BE2-8558-C677FBADDC2CQ36197083-E3C826C2-FCFD-44C2-A4AB-AEA4120F3681Q36329903-CB138E78-B990-4D62-865F-DB7F0F0631FBQ36454515-1E3754FC-6AED-4EAA-9151-F9DE824E265BQ36507543-E09B47B4-5563-4A7F-B464-7D07FD87AA46Q36629185-1A56DD58-4728-40BF-975A-09578A5CD4C7Q36795530-0EA07F4A-C7FF-4ABD-981A-D8FD0602ADC7Q36981641-67CB6FAE-6FFD-4A52-8B23-9C1ABECB352DQ37184415-BB421637-166A-4038-B0F2-E3B991CE8DCFQ37217091-FE86FD65-781A-4E50-8A43-A995B65E0904Q37246781-A4A1CA65-05C9-4865-9735-3C79D6170263Q37341137-F21F6313-BF4B-4903-A233-5F0452EA1FB9Q37558923-192F6A5B-53E9-43FF-851F-C3C7F52EFE04Q37592058-311990D3-ADF5-4098-978A-E1153B9DE7E0Q37607948-C89C91AC-BDDC-4A54-B84F-BFB087FE267DQ38062413-C5FA658B-E108-44EA-B65C-D78036822E8CQ38194625-AD482397-398C-4757-A2B8-28E0FC84E6C1
P2860
Modified-release hydrocortisone to provide circadian cortisol profiles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Modified-release hydrocortisone to provide circadian cortisol profiles.
@en
Modified-release hydrocortisone to provide circadian cortisol profiles.
@nl
type
label
Modified-release hydrocortisone to provide circadian cortisol profiles.
@en
Modified-release hydrocortisone to provide circadian cortisol profiles.
@nl
prefLabel
Modified-release hydrocortisone to provide circadian cortisol profiles.
@en
Modified-release hydrocortisone to provide circadian cortisol profiles.
@nl
P2093
P2860
P356
P1476
Modified-release hydrocortisone to provide circadian cortisol profiles.
@en
P2093
Amin Rostami-Hodjegan
Cyrus Ghobadi
Deborah P Merke
Hiep Huatan
John Newell-Price
Miguel Debono
Richard J Ross
P2860
P304
P356
10.1210/JC.2008-2380
P407
P577
2009-02-17T00:00:00Z